Lingxi Nan

Lingxi Nan

Auto-generated profile, based on publicly available information

Lingxi Nan

Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
LNLingxi Nan
Lingxi Nan
CWChangcheng Wang
Changcheng Wang
YDYajie Dai
Yajie Dai
JWJie Wang
Jie Wang
XBXiaobo Bo
Xiaobo Bo
YWYueqi wang
Yueqi wang
Background: Cystic duct carcinoma (CDC) is a rare biliary malignancy with a low incidence and poor prognosis. However, the clinical landscape of the disease has not been clarified and no widely applicable classification system has been developed. Methods: Sixty-two patients with CDC were included in this retrospective study, and a new classification system was established using imaging data. Blood indices, radiological characteristics, pathological features, surgical procedures, and overall survival data were collected. The efficacy of the new classification in predicting resectability was evaluated using receiver operating characteristic (ROC) curves, and K-means clustering and t-distributed stochastic neighbor embedding were applied to verify the conclusion. Results: The pT stage of patients with type II CDC was significantly worse than that of type I. Patients with type II CDC were more likely to experience distant metastasis and invasion of the nervous system, vascular system, and liver. The resectability of patients with type II CDC was significantly worse than that of patients with type I CDC. Patients with type II CDC had worse prognoses. ROC curve analysis and K-means clustering revealed that the new classification could better categorize patients with CDC than currently available systems. Conclusion: Patients with type II CDC have significantly worse clinicopathological outcomes. The new classification system has better accuracy in grouping patients with CDC.

20 March 2020 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
XBXiaobo Bo
Xiaobo Bo
JWJie Wang
Jie Wang
LNLingxi Nan
Lingxi Nan
YXYanlei Xin
Yanlei Xin
ZGZhihui Gao
Zhihui Gao
HLHoubao Liu
Houbao Liu

25 September 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
LNLingxi Nan
Lingxi Nan
CWChangcheng Wang
Changcheng Wang
JWJie Wang
Jie Wang
SXShijie Xu
Shijie Xu
XBXiaobo Bo
Xiaobo Bo
YWYueqi wang
Yueqi wang